Metabolic syndrome
It
is now abundantly clear that there is a metabolic condition characterized by a
cluster of risk factors for accelerated macrovascular disease. It , in my
opinion, represents about 75% of primary hypertension. This condition –first
described and codified by G. Reaven in the 1980s and termed Syndrome X- has been
considerably refined and is now known as the metabolic syndrome or the insulin
resistance syndrome. The hallmarks of thic condition include obesity (especially
central or troncular), glucose intolerance, hypertension, hypertriglyceridemia,
low HDL cholesterol, hyperuricemia, and a variety of hemostasis abnormalities.
These subjects are at high risk for diabetes and suffer from higher rates of
coronary heart disease morbidity and mortality. Moreover some researchers
identify metabolic syndrome with microvascular angina (angina + positive stress
test for myocardial ischaemia + not narrowed coronaries). While the genetic
basis of the metabolic syndrome is not yet established, it is clearly a
polygenic, multiorgan system disorder. Given the high risk for progression to
diabetes and atherosclerosis, it is of some urgency that these persons be
identified early, have a comprehensive risk factors assessment, and be subjected
to early interventions designed to reduce insulin resistance and ameliorate
cardiovascular risk factors. Identification of high risk persons can be achieved
by application of several screening criteria including waist circumference
measurement, blood pressure and TG/HDL levels, blood glucose assessment, and
family history. While not an algorithm as such, this approach is of practical
utility, and when combined with the non-pharmacologic and pharmacologic
approaches known to reduce insulin resistance, can serve as an effective
intervention for arrest and/or reversal of metabolic syndrome. Particular
attention should be paid to the roles of medical nutrition therapy, physical
activity and insulin sensitizers
Clinical identification of the Metabolic syndrome.
Risk
factor |
Defining
level in men |
Defining
level in women |
Abdominal
obesity Waist
circumference |
>
102 cm (> 40 in) |
>
88 cm (> 35 in) |
Triglycerides |
≥
150 mg/dL |
≥
150 mg/dL |
HDL
cholesterol |
< 40 mg/dL |
< 50 mg/dL |
Blood
pressure |
≥
130/ ≥ 85 mmHg |
≥
130/ ≥ 85 mmHg |
Fasting
glucose |
≥
110 mg/dL |
≥
110 mg/ dL |
press left arrow in your browser for previous page
[Home]